SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010423
Filing Date
2023-05-25
Accepted
2023-05-25 08:30:19
Documents
17
Period of Report
2023-05-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230524x8k.htm   iXBRL 8-K 41438
2 EX-99.1 tmb-20230524xex99d1.htm EX-99.1 8830
3 GRAPHIC tmb-20230524xex99d1001.jpg GRAPHIC 2288
4 GRAPHIC tmb-20230524xex99d1002.jpg GRAPHIC 3616
5 GRAPHIC tmb-20230524xex99d1003.jpg GRAPHIC 2955
6 GRAPHIC tmb-20230524xex99d1004.jpg GRAPHIC 3492
  Complete submission text file 0001558370-23-010423.txt   190351

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20230524.xsd EX-101.SCH 3114
8 EX-101.LAB tmb-20230524_lab.xml EX-101.LAB 15920
9 EX-101.PRE tmb-20230524_pre.xml EX-101.PRE 10046
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230524x8k_htm.xml XML 4850
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 23956274
SIC: 2834 Pharmaceutical Preparations